RBRukaiah Fatma Begum

Rukaiah Fatma Begum

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rukaiah Fatma Begum has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Food‐grade proteins, lipids, and fibers as potential tools to ameliorate cardiovascular disorders: A review

    by Sridevi Shanmugam, Rukaiah Fatma Begum, Nirenjen Shanmugasundaram, Bhupendra Gopalbhai Prajapati, Suresh Ankul Singh, Pavithra Nagenthran, Sudarshan Singh, Kesarla Rajesh

    Cardiovascular diseases (CVDs) remain the leading cause of global mortality, necessitating effective preventive and adjunct therapeutic strategies beyond conventional pharmacological interventions. Although previous reviews have focused on individual nutrients or dietary patterns, this review provides a mechanism‐based, integrative perspective on food‐grade proteins, lipids, and dietary fibers in CVDs. Here, food‐grade refers to nutritionally safe, regulatory‐compliant macronutrients incorporated into functional foods with defined physiological benefits. This review evaluates how these macronutrients target key CVD pathways. Food‐grade proteins release bioactive peptides with ACE‐inhibitory, lipid‐lowering, and endothelial‐protective effects. Functional lipids, particularly omega‐3 fatty acids and phytosterols, regulate lipid metabolism, stabilize atherosclerotic plaques, and reduce inflammation. Soluble dietary fibers such as β‐glucan, psyllium, and pectin lower cholesterol absorption, improve glycemic control, and modulate gut microbiota. Importantly, this review highlights synergistic and antagonistic interactions among these macronutrients within real food matrices, emphasizing their combined influence on digestion, bioavailability, and metabolic responses. Dose–response relationships and practical intake considerations are also discussed to bridge mechanistic insights with dietary applications. Collectively, this framework positions food‐grade macronutrients as interactive modulators of cardiovascular health rather than isolated components. Future research should focus on validating nutrient interactions, optimizing synergistic formulations, and establishing clinically effective intake thresholds.


  • Open Access

    Unleashing light's healing power: an overview of photobiomodulation for Alzheimer's treatment

    by Aakash Ramanishankar, Ankul Singh S, Rukaiah F Begum, Narayanan Jayasankar, Afreen Nayeem, Bhupendra G Prajapati, Shanmugasundaram Nirenjen

    Aim: Photobiomodulation involves the use of low-level light therapy or near-infrared light therapy found to be useful in the treatment of a wide range of neurological diseases. Objective: The aim i... Plain language summary Alzheimer's disease (AD) is an incurable progressive neurodegenerative disease clinically manifested with a decline in cognitive function. To ensure that the consensus statem...


  • Open Access

    Navigating neurological disorders

    by Rapuru Rushendran, Rukaiah Fatma Begum, Ankul Singh S, Pavithra Lakshmi Narayanan, Chitra Vellapandian, Bhupendra G. Prajapati, Pijush Kumar Paul

    Novel treatments are needed as neurological issues become more frequent worldwide. According to the report, plants, oceans, microorganisms, and animals contain interesting drug discovery compounds. Alzheimer's, Parkinson's, and stroke reviews emphasize neurological disorders’ complexity and natural substances’ safety. Learn about marine-derived and herbal substances’ neuroprotective characteristics and applications. Molecular pathways show these substances’ neurological healing effects. This article discusses clinical usage of Bryostatin-1, Fucoidan, Icariin, Salvianolic acid, Curcumin, Resveratrol, etc. Their potential benefits for asthma and Alzheimer’s disease are complex. Although limited, the study promotes rigorous scientific research and collaboration between traditional and alternative medical practitioners. Unexplored natural compounds, quality control, well-structured clinical trials, and interdisciplinary collaboration should guide future study. Developing and employing natural chemicals to treat neurological illnesses requires ethical sourcing, sustainability, and public awareness. This detailed analysis covers natural chemicals’ current state, challenges, and opportunities in neurological disorder treatment.


  • Open Access

    Systematic exploration of network pharmacology, in silico modeling and pharmacokinetic profiling for vitamin E in polycystic ovarian syndrome

    by Rukaiah Fatma Begum, Sumithra Mohan

    Aim: This study seeks to explore the possibility of using vitamin E to alleviate the symptoms of polycystic ovarian syndrome (PCOS). Methods: Various computational methods were employed, including ... Plain language summary Polycystic ovarian syndrome (PCOS) is a common condition that affects many girls and young women during their reproductive years. PCOS can lead to problems with the menstrual...